XML 43 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Consolidated Statements of Shareholders' Equity Statement - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Treasury Shares
Capital in excess of stated value
Retained earnings
Accumulated other comprehensive loss
Beginning balance at Mar. 31, 2018 $ 108,431 $ 9,482 $ (2,486) $ (1,911) $ 103,601 $ (255)
Beginning balance (in shares) at Mar. 31, 2018   31,607 (8,283)      
Cumulative effect of change in accounting policy 2,614       2,614  
Share-based compensation 2,868     2,868    
Restricted shares issued, net     $ 52 (52)    
Restricted shares issued, net (in shares)     175      
Shares issued upon exercise of SSARs     $ 16 (16)    
Shares issued upon exercise of SSARs (in shares)     53      
Shares withheld for taxes upon exercise of stock options, SSARs or vesting of restricted shares (254)   $ (4) (250)    
Shares withheld for taxes upon exercise of stock options, SSARs or vesting of restricted shares (in shares)     (16)      
Net loss (9,575)       (9,575)  
Unrealized translation adjustments 21         21
Ending balance at Dec. 31, 2018 104,105 $ 9,482 $ (2,422) 639 96,640 (234)
Ending balance (in shares) at Dec. 31, 2018   31,607 (8,071)      
Beginning balance at Sep. 30, 2018 106,974 $ 9,482 $ (2,424) (451) 100,688 (321)
Beginning balance (in shares) at Sep. 30, 2018   31,607 (8,077)      
Share-based compensation 1,147     1,147    
Restricted shares issued, net     $ 2 (2)    
Restricted shares issued, net (in shares)     7      
Shares issued upon exercise of SSARs     $ 1 (1)    
Shares issued upon exercise of SSARs (in shares)     2      
Shares withheld for taxes upon exercise of stock options, SSARs or vesting of restricted shares (55)   $ (1) (54)    
Shares withheld for taxes upon exercise of stock options, SSARs or vesting of restricted shares (in shares)     (3)      
Net loss (4,048)       (4,048)  
Unrealized translation adjustments 87         87
Ending balance at Dec. 31, 2018 104,105 $ 9,482 $ (2,422) 639 96,640 (234)
Ending balance (in shares) at Dec. 31, 2018   31,607 (8,071)      
Beginning balance at Mar. 31, 2019 100,622 $ 9,482 $ (2,433) 781 93,051 (259)
Beginning balance (in shares) at Mar. 31, 2019   31,607 (8,105)      
Share-based compensation 3,479     3,479    
Restricted shares issued, net     $ 42 (42)    
Restricted shares issued, net (in shares)     143      
Shares issued upon exercise of SSARs     $ 5 (5)    
Shares issued upon exercise of SSARs (in shares)     17      
Shares withheld for taxes upon exercise of stock options, SSARs or vesting of restricted shares (120)   $ (1) (119)    
Shares withheld for taxes upon exercise of stock options, SSARs or vesting of restricted shares (in shares)     (5)      
Net loss (7,075)       (7,075)  
Unrealized translation adjustments 30         30
Ending balance at Dec. 31, 2019 96,936 $ 9,482 $ (2,387) 4,094 85,976 (229)
Ending balance (in shares) at Dec. 31, 2019   31,607 (7,950)      
Beginning balance at Sep. 30, 2019 98,365 $ 9,482 $ (2,386) 2,909 88,558 (198)
Beginning balance (in shares) at Sep. 30, 2019   31,607 (7,949)      
Share-based compensation 1,184     1,184    
Restricted shares issued, net     $ (1) 1    
Restricted shares issued, net (in shares)     (1)      
Net loss (2,582)       (2,582)  
Unrealized translation adjustments (31)         (31)
Ending balance at Dec. 31, 2019 $ 96,936 $ 9,482 $ (2,387) $ 4,094 $ 85,976 $ (229)
Ending balance (in shares) at Dec. 31, 2019   31,607 (7,950)